Skip to main content
Premium Trial:

Request an Annual Quote

Genizon BioSciences Adopts Illumina s BeadChips for Disease-Association Research

NEW YORK, Jan. 12 (GenomeWeb News) - Genizon BioSciences will use Illumina's whole-genome genotyping platform for its disease-association research program, Illumina said today.


Genizon will conduct whole genome-association studies on at least 16,000 case and control samples in 11 common diseases over the next year and a half, Illumina said. Genizon has completed three such studies.


DNA samples will be collected in collaboration with over 900 clinical investigators in Quebec. Genizon will use a custom version of Illumina's Sentrix HumanHap300 BeadChip, tailored to genetic sharing in the Quebec population, to query over 350,000 SNP loci per sample.


Genizon will expand its existing Illumina system with six additional BeadArray Readers, extensive automation, LIMS to integrate workflows, and new BeadStudio software.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.